Plasma heparin concentrations during subcutaneous heparin therapy

Area of Science:

• Pharmacokinetics and Pharmacodynamics
• Biochemistry
• Medical Research

Background:

• Heparin is a widely used anticoagulant medication.
• Understanding heparin pharmacokinetics is crucial for effective and safe therapeutic use.
• Subcutaneous administration is a common route for heparin delivery.

Purpose of the Study:

• To investigate plasma heparin concentrations following subcutaneous injection of varying doses.
• To determine the time to peak plasma concentration and the influence of dose.
• To explore correlations between heparin levels and patient demographics.

Main Methods:

• Subcutaneous injection of heparin (1000, 5000, 10,000 units).
• Measurement of plasma heparin concentrations at two-hourly intervals.
• Analysis of data considering dose, time, and patient characteristics (age, sex, weight).

Main Results:

• Peak plasma heparin concentrations were most frequently observed 4 hours post-injection for 5000 and 10,000 unit doses.
• Significant variability in peak concentrations was noted, with considerable overlap between dose groups.
• No correlation was found between plasma heparin concentration and patient age, sex, or weight.
• Only trace amounts of heparin were detected after a 1000 unit injection.
• Calcium and sodium heparin salts yielded comparable results up to 6 hours post-injection.

Conclusions:

• Subcutaneous heparin dosing of 5000-10,000 units leads to peak plasma levels around 4 hours.
• Patient factors do not reliably predict plasma heparin concentrations after subcutaneous administration.
• Lower doses (1000 units) result in minimal detectable heparin levels.